These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 29575033)

  • 21. Spinocerebellar ataxia types 1, 2, 3 and 6: the clinical spectrum of ataxia and morphometric brainstem and cerebellar findings.
    Jacobi H; Hauser TK; Giunti P; Globas C; Bauer P; Schmitz-Hübsch T; Baliko L; Filla A; Mariotti C; Rakowicz M; Charles P; Ribai P; Szymanski S; Infante J; van de Warrenburg BP; Dürr A; Timmann D; Boesch S; Fancellu R; Rola R; Depondt C; Schöls L; Zdzienicka E; Kang JS; Ratzka S; Kremer B; Stephenson DA; Melegh B; Pandolfo M; Tezenas du Montcel S; Borkert J; Schulz JB; Klockgether T
    Cerebellum; 2012 Mar; 11(1):155-66. PubMed ID: 21701895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dystonia and ataxia progression in spinocerebellar ataxias.
    Kuo PH; Gan SR; Wang J; Lo RY; Figueroa KP; Tomishon D; Pulst SM; Perlman S; Wilmot G; Gomez CM; Schmahmann JD; Paulson H; Shakkottai VG; Ying SH; Zesiewicz T; Bushara K; Geschwind MD; Xia G; Subramony SH; Ashizawa T; Kuo SH
    Parkinsonism Relat Disord; 2017 Dec; 45():75-80. PubMed ID: 29089256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine transporter positron emission tomography in spinocerebellar ataxias type 1, 2, 3, and 6.
    Wüllner U; Reimold M; Abele M; Bürk K; Minnerop M; Dohmen BM; Machulla HJ; Bares R; Klockgether T
    Arch Neurol; 2005 Aug; 62(8):1280-5. PubMed ID: 16087769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study.
    Ashizawa T; Figueroa KP; Perlman SL; Gomez CM; Wilmot GR; Schmahmann JD; Ying SH; Zesiewicz TA; Paulson HL; Shakkottai VG; Bushara KO; Kuo SH; Geschwind MD; Xia G; Mazzoni P; Krischer JP; Cuthbertson D; Holbert AR; Ferguson JH; Pulst SM; Subramony SH
    Orphanet J Rare Dis; 2013 Nov; 8():177. PubMed ID: 24225362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms.
    Schmitz-Hübsch T; Coudert M; Bauer P; Giunti P; Globas C; Baliko L; Filla A; Mariotti C; Rakowicz M; Charles P; Ribai P; Szymanski S; Infante J; van de Warrenburg BP; Dürr A; Timmann D; Boesch S; Fancellu R; Rola R; Depondt C; Schöls L; Zdienicka E; Kang JS; Döhlinger S; Kremer B; Stephenson DA; Melegh B; Pandolfo M; di Donato S; du Montcel ST; Klockgether T
    Neurology; 2008 Sep; 71(13):982-9. PubMed ID: 18685131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autosomal dominant cerebellar ataxias: Imaging biomarkers with high effect sizes.
    Adanyeguh IM; Perlbarg V; Henry PG; Rinaldi D; Petit E; Valabregue R; Brice A; Durr A; Mochel F
    Neuroimage Clin; 2018; 19():858-867. PubMed ID: 29922574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Initial Symptom and Motor Progression in Spinocerebellar Ataxias.
    Luo L; Wang J; Lo RY; Figueroa KP; Pulst SM; Kuo PH; Perlman S; Wilmot G; Gomez CM; Schmahmann J; Paulson H; Shakkottai VG; Ying SH; Zesiewicz T; Bushara K; Geschwind M; Xia G; Subramony SH; Ashizawa T; Kuo SH
    Cerebellum; 2017 Jun; 16(3):615-622. PubMed ID: 27848087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A longitudinal investigation into cognition and disease progression in spinocerebellar ataxia types 1, 2, 3, 6, and 7.
    Moriarty A; Cook A; Hunt H; Adams ME; Cipolotti L; Giunti P
    Orphanet J Rare Dis; 2016 Jun; 11(1):82. PubMed ID: 27333979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis and hierarchical clustering of infratentorial morphological MRI identifies SCAs phenogroups.
    Zhao J; Zeng W; Huang X; Hu M; Yuan K; Wu C; Qiu H; Chu J
    J Neurol; 2023 Sep; 270(9):4466-4477. PubMed ID: 37291395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Noninvasive detection of presymptomatic and progressive neurodegeneration in a mouse model of spinocerebellar ataxia type 1.
    Oz G; Nelson CD; Koski DM; Henry PG; Marjanska M; Deelchand DK; Shanley R; Eberly LE; Orr HT; Clark HB
    J Neurosci; 2010 Mar; 30(10):3831-8. PubMed ID: 20220018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term evolution of patient-reported outcome measures in spinocerebellar ataxias.
    Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Sarro L; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Nachbauer W; Kang JS; Pandolfo M; Schulz JB; Melac AT; Diallo A; Klockgether T
    J Neurol; 2018 Sep; 265(9):2040-2051. PubMed ID: 29959555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurochemical Differences in Spinocerebellar Ataxia Type 14 and 1.
    Grosch AS; Rinnenthal JL; Rönnefarth M; Lux S; Scheel M; Endres M; Brandt AU; Paul F; Schmitz-Hübsch T; Minnerop M; Doss S
    Cerebellum; 2021 Apr; 20(2):169-178. PubMed ID: 33063293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disease progression of spinocerebellar ataxia types 1, 2, 3 and 6 before and after ataxia onset.
    Jacobi H; Schaprian T; Schmitz-Hübsch T; Schmid M; Klockgether T;
    Ann Clin Transl Neurol; 2023 Oct; 10(10):1833-1843. PubMed ID: 37592453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sensitivity of Advanced Magnetic Resonance Imaging to Progression over Six Months in Early Spinocerebellar Ataxia.
    Rezende TJR; Petit E; Park YW; Tezenas du Montcel S; Joers JM; DuBois JM; Moore Arnold H; Povazan M; Banan G; Valabregue R; Ehses P; Faber J; Coupé P; Onyike CU; Barker PB; Schmahmann JD; Ratai EM; Subramony SH; Mareci TH; Bushara KO; Paulson H; Klockgether T; Durr A; Ashizawa T; Lenglet C; Öz G;
    Mov Disord; 2024 Oct; 39(10):1856-1867. PubMed ID: 39056163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and neuroradiological features of patients with spinocerebellar ataxias from Korean kindreds.
    Bang OY; Huh K; Lee PH; Kim HJ
    Arch Neurol; 2003 Nov; 60(11):1566-74. PubMed ID: 14623729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eye Movement Abnormalities Are Ubiquitous in the Spinocerebellar Ataxias.
    Stephen CD; Schmahmann JD
    Cerebellum; 2019 Dec; 18(6):1130-1136. PubMed ID: 31175630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural history of most common spinocerebellar ataxia: a systematic review and meta-analysis.
    Diallo A; Jacobi H; Tezenas du Montcel S; Klockgether T
    J Neurol; 2021 Aug; 268(8):2749-2756. PubMed ID: 32266540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6.
    Reetz K; Costa AS; Mirzazade S; Lehmann A; Juzek A; Rakowicz M; Boguslawska R; Schöls L; Linnemann C; Mariotti C; Grisoli M; Dürr A; van de Warrenburg BP; Timmann D; Pandolfo M; Bauer P; Jacobi H; Hauser TK; Klockgether T; Schulz JB;
    Brain; 2013 Mar; 136(Pt 3):905-17. PubMed ID: 23423669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARA captures disparate progression and responsiveness in spinocerebellar ataxias.
    Petit E; Schmitz-Hübsch T; Coarelli G; Jacobi H; Heinzmann A; Figueroa KP; Perlman SL; Gomez CM; Wilmot GR; Schmahmann JD; Ying SH; Zesiewicz TA; Paulson HL; Shakkottai VG; Bushara KO; Kuo SH; Geschwind MD; Xia G; Pulst SM; Subramony SH; Ewenczyk C; Brice A; Durr A; Klockgether T; Ashizawa T; Tezenas du Montcel S
    J Neurol; 2024 Jul; 271(7):3743-3753. PubMed ID: 38822840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebellar Volumetry in Ataxias: Relation to Ataxia Severity and Duration.
    Ferreira M; Schaprian T; Kügler D; Reuter M; Deike-Hoffmann K; Timmann D; Ernst TM; Giunti P; Garcia-Moreno H; van de Warrenburg B; van Gaalen J; de Vries J; Jacobi H; Steiner KM; Öz G; Joers JM; Onyike C; Povazan M; Reetz K; Romanzetti S; Klockgether T; Faber J
    Cerebellum; 2024 Aug; 23(4):1521-1529. PubMed ID: 38363498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.